Team of Experts Develop Nasal Spray Against COVID-19 Virus |
|
|
|
The University of California at San Francisco successfully developed a nasal spray with one of the most potent SARS-CoV-2 antivirals yet discovered. Known as AeroNabs, it is promising protection against the COVID-19 virus until a vaccine becomes available. The performance of the antiviral is published in bioRxiv.
|
|
|
|
|
|
|
Groups Push for Bt Brinjal Field Trials in India |
|
|
|
Alliance for Agri Innovation (AAI), a group from the Federation of Seed Industry of India (FSII) has urged the central and state governments to allow the field trials of Bt Brinjal in India and sent a letter to the Ministry of Agriculture and chief ministers of Madhya Pradesh, Karnataka, Bihar, Chhattisgarh, Jharkhand, Tamil Nadu, Odisha, and West Bengal to bring their attention to this matter.
|
|
|
|
|
Yield10's CRISPR Genome-Edited C3007 Canola Trait in 2021 US Field Tests |
|
|
Yield10 Bioscience has received a positive response from USDA-APHIS's Biotechnology Regulatory Services (BRS) for its CRISPR genome-edited trait C3007 in canola plant lines developed for increased oil content. The CRISPR-edited C3007 trait designed to increase oil content could deliver significant economic value for the commercialization of identity-preserved, specialty oilseed crops.
|
|
|
|
|
|
|
|
A biweekly update on genome editing research, regulations, and impact
produced by ISAAA Inc. |
| |
|
|
|
| A monthly update on gene drive research and development provided by ISAAA in collaboration with the Outreach Network for Gene Drive Research |
| |
|
|
|
|
GM APPROVAL UPDATES |
- The Philippines approved the eggplant event EE-1 for cultivation
- Nigeria approved the wheat event HB4 for food and feed.
- The USA approved the corn event MON87429 for food and feed.
- Ghana approved the cowpea event AAT709A for food, feed, and cultivation.
- The USA approved the wheat event HB4 for food and feed.
- Turkey approved the maize event MON87427 for feed.
|
|
|
|
| Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10. |
|
|
|
|
